| ALKS Snapshot | |
|---|---|
| Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland. | |
| VALUATION DATA | |
| Market Capitalization | $4,104,404,000 | Price to Sales | 5.00 |
| Earnings per Share | $3.0600 |
| PE Ratio | 7.93 |
| PRICE DATA | |
| Most Recent Close | $24.6500 |
| 52 Week High | $2.453 |
| 52 Week Low | $3.392 |
| 50-Day Moving Average | $2.212 |
| 200-Day Moving Average | $7.08 |
| All data are from Alpha Vantage as of today. For more infomation on ALKS see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search